These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9873486)

  • 1. Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[[(4-chlorophenyl)sulfonyl]-amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists.
    Dack KN; Dickinson RP; Long CJ; Steele J
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2061-6. PubMed ID: 9873486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
    Dickinson RP; Dack KN; Long CJ; Steele J
    J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane A2 receptor antagonists.
    Marusawa H; Setoi H; Kuroda A; Sawada A; Seki J; Motoyama Y; Tanaka H
    Bioorg Med Chem; 1999 Nov; 7(11):2635-45. PubMed ID: 10632075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-(3-(3-pyridinyl) propyl)octanoic acid and analogs.
    Bhagwat SS; Gude C; Boswell C; Contardo N; Cohen DS; Dotson R; Mathis J; Lee W; Furness P; Zoganas H
    J Med Chem; 1992 Nov; 35(23):4373-83. PubMed ID: 1447738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 3. Pyridinylalkyl-substituted 8-[(arylsulfonyl)amino]octanoic acids.
    Main AJ; Bhagwat SS; Boswell C; Goldstein R; Gude C; Cohen DS; Furness P; Lee W; Louzan M
    J Med Chem; 1992 Nov; 35(23):4366-72. PubMed ID: 1447737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel thiazolidine derivatives as thromboxane A2 receptor antagonists.
    Sato M; Kawashima Y; Goto J; Yamane Y; Chiba Y; Jinno S; Satake M; Imanishi T; Iwata C
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):521-9. PubMed ID: 8004696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and thromboxane A2/prostaglandin H2 receptor antagonistic activity of phenol derivatives.
    Fukumoto S; Shiraishi M; Terashita Z; Ashida Y; Inada Y
    J Med Chem; 1992 Jun; 35(12):2202-9. PubMed ID: 1535377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors.
    Cimetière B; Dubuffet T; Landras C; Descombes JJ; Simonet S; Verbeuren TJ; Lavielle G
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1381-6. PubMed ID: 9871770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 5. Synthesis and evaluation of enantiomers of 8-[[(4-chlorophenyl)sulfonyl]amino]-4-(3-pyridinylalkyl)octanoic acid.
    Bhagwat SS; Gude C; Cohen DS; Dotson R; Mathis J; Lee W; Furness P
    J Med Chem; 1993 Jan; 36(2):205-10. PubMed ID: 8423593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
    J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.
    Main AJ; Goldstein R; Cohen DS; Furness P; Lee W
    J Med Chem; 1992 Nov; 35(23):4362-5. PubMed ID: 1447736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.
    Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ
    J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and pharmacology of 3-substituted sodium azulene-1-sulfonates and related compounds: non-prostanoid thromboxane A2 receptor antagonists.
    Tomiyama T; Yokota M; Wakabayashi S; Kosakai K; Yanagisawa T
    J Med Chem; 1993 Apr; 36(7):791-800. PubMed ID: 8464032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors.
    Soyka R; Heckel A; Nickl J; Eisert W; Müller TH; Weisenberger H
    J Med Chem; 1994 Jan; 37(1):26-39. PubMed ID: 8289199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
    Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
    J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis and thromboxane A2 (TXA2) receptor antagonistic activity of optically active phenol derivatives.
    Fukumoto S; Terashita Z; Ashida Y; Terao S; Shiraishi M
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):749-55. PubMed ID: 8681407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 2.
    Ohshima E; Takami H; Sato H; Mohri S; Obase H; Miki I; Ishii A; Shirakura S; Karasawa A; Kubo K
    J Med Chem; 1992 Sep; 35(18):3402-13. PubMed ID: 1388208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.